Relevate Health, on a digital marketing buyout spree, snaps up Axon Communicationsnews2022-02-23T10:15:00+00:00February 23rd, 2022|Fierce Pharma|
Biohaven lines up rhinosinusitis patients for trial of its migraine med Nurtec ODTnews2022-02-22T16:27:30+00:00February 22nd, 2022|Fierce Pharma|
March-in campaign on Pfizer’s prostate cancer med Xtandi gets congressional backing. Will it matter?news2022-02-22T15:38:29+00:00February 22nd, 2022|Fierce Pharma|
Novartis’ Leqvio to reap $2.5B by 2027 thanks to convenience edge over Amgen, Sanofi rivals: analystnews2022-02-22T14:47:13+00:00February 22nd, 2022|Fierce Pharma|
J&J to shutter Pennsylvania OTC manufacturing plant by 2023, reportnews2022-02-22T14:36:41+00:00February 22nd, 2022|Fierce Pharma|
GlaxoSmithKline unveils Haleon, the new brand name for its outgoing consumer health unitnews2022-02-22T14:25:11+00:00February 22nd, 2022|Fierce Pharma|
AstraZeneca CEO snared more than $18M last year as his company worked through highs and lows of vaccine launchnews2022-02-22T14:07:04+00:00February 22nd, 2022|Fierce Pharma|
Valneva reaps $27M development grant to boost Scottish production sitenews2022-02-22T13:38:09+00:00February 22nd, 2022|Fierce Pharma|
Targeting a $300M market, Almirall starts selling ‘less greasy’ psoriasis cream in the EUnews2022-02-22T11:31:58+00:00February 22nd, 2022|Fierce Pharma|
AstraZeneca, Daiichi target broad breast cancer use with Enhertu’s landmark win in HER2-low diseasenews2022-02-22T11:27:14+00:00February 22nd, 2022|Fierce Pharma|
